0
     

Report Added
Report already added
ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027

ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027

The global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, increasing prevalence of cancer and other chronic and infectious diseases, and the shift from culture-based tests to rapid tests. However, the high cost of instruments and inability to differentiate between extracellular and intracellular ATP are expected to restrain the growth of this market to a certain extent.

“The consumables and accessories segment accounted for the largest share of the ATP assays, based on product in 2021.”

Based on products, the ATP assays market is segmented into consumables & accessories and instruments. The large share of consumables & accessories segment is attributed to the extensive usage of ATP assays in research institutes to measure cell viability, increase in drug discovery due to a surge in chronic diseases which requires tumor testing and cell proliferation (in cancer), and the repeated purchase of consumables by pharmaceutical and biotechnology companies.

“Contamination Testing accounted for the largest share of the market.”

The ATP assays market is segmented into contamination testing, disease testing, and drug discovery & development. The large share of the contamination testing segment can be attributed to the rising regulatory stringency of pharmaceutical and food & beverage companies for non-contaminated production, an increase in drug discovery post COVID-19, and the need for cleaning and disinfection of environmental surfaces in hospitals.

“Pharmaceutical & Biotechnology companies hold the largest share in the market, by end user”

The large share of Pharmaceutical & Biotechnology companies in the end user segment can be attributed to the presence of a large number of pharmaceutical players with growing investments in this market, growing regulatory approvals for cell culture-based vaccines which require the use of ATP assays in contamination testing, commercial expansion of various pharmaceutical companies, the increasing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical & biopharmaceutical companies, increasing production of COVID-19 drugs, increasing adoption of cell-based assays for drug development, and the ease of use of ATP assays in contamination testing.

“The APAC to witness the highest growth during the forecast period.”

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2022–2027. This regional market is expected to register the highest growth rate during the forecast period as several APAC countries are witnessing a growing number of proteomics, genomics, and stem cell research activities. The increasing incidence of chronic & infectious diseases, increasing drug discovery & development studies, favorable regulatory guidelines, the growing focus of global market players on emerging Asian economies, increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and research infrastructure modernization are some of the key factors driving the market for ATP assays.

Break of primary participants was as mentioned below:
•By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
•By Designation – C-level–35%, Director-level–25%, Others–40%
•By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the ATP Assays Market
The prominent players in the ATP assays market are Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), NEOGEN Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech LLC (US), Cayman Chemical (US), and Cell Signaling Technology (US).

Research Coverage:
The report analyzes the ATP assays market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes a product portfolio matrix of various ATP assays products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the ATP assays market. The report analyzes this market by product, by application, and by end user.
•Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global ATP assays market
•Market Development: Comprehensive information on the lucrative emerging markets by product, application, and end user
•Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global ATP assays market
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global ATP assays market.
Table of Contents

1INTRODUCTION24
1.1OBJECTIVES OF THE STUDY24
1.2MARKET DEFINITION & SCOPE24
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY25
1.2.2MARKET SEGMENTATION25
FIGURE 1ATP ASSAYS MARKET SEGMENTATION25
1.2.3YEARS CONSIDERED FOR THE STUDY26
1.3CURRENCY26
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD26
1.4STAKEHOLDERS27
1.5SUMMARY OF CHANGES27
2RESEARCH METHODOLOGY29
2.1RESEARCH DATA29
FIGURE 2RESEARCH DESIGN29
2.1.1SECONDARY DATA29
2.1.1.1Key data from secondary sources30
2.1.2PRIMARY DATA31
FIGURE 3PRIMARY SOURCES31
2.1.2.1Key data from primary sources32
2.1.2.2Key industry insights32
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS33
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS33
FIGURE 6BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS34
2.2MARKET SIZE ESTIMATION34
FIGURE 7MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS35
FIGURE 8REVENUE SHARE ANALYSIS ILLUSTRATION35
FIGURE 9CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES37
FIGURE 10CAGR PROJECTIONS37
FIGURE 11TOP-DOWN APPROACH38
2.3MARKET BREAKDOWN & DATA TRIANGULATION39
FIGURE 12DATA TRIANGULATION METHODOLOGY39
2.4MARKET RANKING ANALYSIS40
2.5ASSUMPTIONS FOR THE STUDY40
2.6LIMITATIONS40
2.6.1METHODOLOGY-RELATED LIMITATIONS40
2.6.2SCOPE-RELATED LIMITATIONS41
2.7RISK ASSESSMENT41
TABLE 2RISK ASSESSMENT: ATP ASSAYS MARKET41
3EXECUTIVE SUMMARY42
FIGURE 13ATP ASSAYS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)42
FIGURE 14ATP ASSAYS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)43
FIGURE 15ATP ASSAYS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)43
FIGURE 16GEOGRAPHICAL SNAPSHOT OF THE ATP ASSAYS MARKET44
4PREMIUM INSIGHTS46
4.1ATP ASSAYS MARKET OVERVIEW46
FIGURE 17INCREASING FOOD SAFETY CONCERNS TO DRIVE MARKET GROWTH46
4.2ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER AND COUNTRY (2021)47
FIGURE 18PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 202147
4.3ATP ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES48
FIGURE 19CHINA TO REGISTER THE HIGHEST GROWTH IN THE ATP ASSAYS MARKET DURING THE FORECAST PERIOD48
4.4ATP ASSAYS MARKET, BY REGION (2020–2027)49
FIGURE 20NORTH AMERICA WILL CONTINUE TO DOMINATE THE ATP ASSAYS MARKET IN 202749
4.5ATP ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS49
FIGURE 21DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD49
5MARKET OVERVIEW50
5.1INTRODUCTION50
5.2MARKET DYNAMICS50
TABLE 3ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES50
5.2.1MARKET DRIVERS51
5.2.1.1Increasing food safety concerns51
5.2.1.2Growing demand for ATP assays in pharmaceutical & biotechnology companies52
5.2.1.3Rising investments in pharmaceutical & biotechnology R&D52
FIGURE 22GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 (USD BILLION)53
5.2.1.4Increasing prevalence of cancer53
FIGURE 23GLOBAL CANCER INCIDENCE, 2018 VS. 2030 (MILLION)54
5.2.1.5Shift from culture-based tests to rapid-tests54
5.2.1.6Rising incidence and prevalence of chronic and infectious diseases55
5.2.2MARKET RESTRAINTS56
5.2.2.1High cost of instruments56
5.2.2.2Inability to differentiate between extracellular and intracellular ATP56
5.2.3MARKET OPPORTUNITIES57
5.2.3.1Technological enhancements in ATP assay probes57
5.2.3.2Growth prospects in emerging markets57
5.2.4MARKET CHALLENGES58
5.2.4.1Survival of small players and new entrants58
5.3INDUSTRY TRENDS58
5.3.1INCREASING REGULATIONS FOR FOOD BUSINESSES58
5.3.2ADOPTION OF ATP TESTING FOR MONITORING ENVIRONMENTAL CONTAMINATION CAUSED BY SARS-COV-259
5.4IMPACT OF COVID-19 ON THE ATP ASSAYS MARKET59
5.5PATENT ANALYSIS60
5.5.1PATENT PUBLICATION TRENDS FOR ATP ASSAYS60
FIGURE 24PATENT PUBLICATION TRENDS (JANUARY 2011–FEBRUARY 2022)61
5.5.2INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS61
FIGURE 25TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTES) FOR ATP ASSAY PATENTS (JANUARY 2011–FEBRUARY 2022)62
FIGURE 26TOP APPLICANT COUNTRIES/REGIONS FOR ATP ASSAYS
(JANUARY 2011–FEBRUARY 2022)63
5.5.3LIST OF PATENTS/PATENT APPLICATIONS IN THE ATP ASSAYS MARKET63
5.6VALUE CHAIN ANALYSIS65
FIGURE 27ATP ASSAYS MARKET: VALUE CHAIN ANALYSIS65
5.7ECOSYSTEM ANALYSIS66
FIGURE 28ATP ASSAYS MARKET: ECOSYSTEM ANALYSIS66
5.8PORTER’S FIVE FORCES ANALYSIS66
TABLE 4ATP ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS66
5.8.1THREAT OF NEW ENTRANTS67
5.8.2THREAT OF SUBSTITUTES67
5.8.3BARGAINING POWER OF SUPPLIERS67
5.8.4BARGAINING POWER OF BUYERS68
5.8.5INTENSITY OF COMPETITIVE RIVALRY68
5.9PRICING ANALYSIS68
5.9.1REGIONAL PRICING ANALYSIS OF ATP ASSAYS, 2021 (USD)69
6ATP ASSAYS MARKET, BY PRODUCT70
6.1INTRODUCTION71
TABLE 5ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)71
6.2CONSUMABLES & ACCESSORIES71
TABLE 6KEY ATP CONSUMABLES & ACCESSORIES AVAILABLE IN THE MARKET72
TABLE 7ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)72
TABLE 8ATP CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)73
6.2.1REAGENTS & KITS73
6.2.1.1Reagents play a significant role in the identification and detection of cells in cancer research73
TABLE 9REAGENTS & KITS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)74
6.2.2MICROPLATES75
6.2.2.1Extensive use of microplates for assay development is driving their adoption75
TABLE 10MICROPLATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)76
6.2.3OTHER CONSUMABLES & ACCESSORIES76
TABLE 11OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)77
6.3INSTRUMENTS77
TABLE 12ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)77
TABLE 13ATP INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)78
TABLE 14KEY ATP INSTRUMENTS AVAILABLE IN THE MARKET78
6.3.1LUMINOMETERS79
6.3.1.1Luminometers are comparatively low-priced and, therefore, widely adopted79
TABLE 15LUMINOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)79
6.3.2SPECTROPHOTOMETERS80
6.3.2.1Spectrophotometers are costlier than luminometers and, therefore, less preferred by end users in the ATP assays market80
TABLE 16SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)80
7ATP ASSAYS MARKET, BY APPLICATION81
7.1INTRODUCTION82
TABLE 17ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)82
7.2CONTAMINATION TESTING82
7.2.1NEED TO MEET REGULATORY MANDATES FOR CONTAMINATION AND QUALITY TESTING IS A KEY FACTOR DRIVING MARKET GROWTH82
TABLE 18ATP ASSAYS MARKET FOR CONTAMINATION TESTING, BY COUNTRY,
2020–2027 (USD MILLION)83
7.3DISEASE TESTING83
7.3.1GROWING DISEASE INCIDENCE AND RISING AWARENESS ARE EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD83
TABLE 19ATP ASSAYS MARKET FOR DISEASE TESTING, BY COUNTRY,
2020–2027 (USD MILLION)85
7.4DRUG DISCOVERY & DEVELOPMENT85
7.4.1INCREASING R&D PIPELINE FOR PHARMACEUTICAL DRUGS WILL DRIVE MARKET GROWTH85
TABLE 20ATP ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)86
8ATP ASSAYS MARKET, BY END USER87
8.1INTRODUCTION88
TABLE 21ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)88
8.2PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES88
8.2.1PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF ATP ASSAYS88
TABLE 22ATP ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)89
8.3FOOD & BEVERAGE INDUSTRY90
8.3.1RISING INCIDENCE OF FOOD CONTAMINATION TO DRIVE THE ADOPTION OF ATP ASSAYS90
TABLE 23ATP ASSAYS MARKET FOR FOOD & BEVERAGE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)91
8.4HOSPITALS & DIAGNOSTIC LABORATORIES91
8.4.1GROWING DEMAND FOR EARLY DISEASE DIAGNOSIS IS A MAJOR FACTOR DRIVING THE ADOPTION OF ATP ASSAYS91
TABLE 24ATP ASSAYS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2020–2027 (USD MILLION)92
8.5ACADEMIC & RESEARCH INSTITUTES93
8.5.1ATP ASSAYS ARE USED FOR RESEARCH ACTIVITIES RELATED TO THE GROWTH RATE & VIABILITY OF MICROORGANISMS93
TABLE 25ATP ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)93
9ATP ASSAYS MARKET, BY REGION94
9.1INTRODUCTION95
TABLE 26ATP ASSAYS MARKET, BY REGION, 2020–2027 (USD MILLION)96
9.2NORTH AMERICA96
FIGURE 30NORTH AMERICA: ATP ASSAYS MARKET SNAPSHOT97
TABLE 27NORTH AMERICA: ATP ASSAYS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)98
TABLE 28NORTH AMERICA: ATP ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)98
TABLE 29NORTH AMERICA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)98
TABLE 30NORTH AMERICA: ATP INSTRUMENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)99
TABLE 31NORTH AMERICA: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)99
TABLE 32NORTH AMERICA: ATP ASSAYS MARKET, BY END USER,
2020–2027 (USD MILLION)99
9.2.1US100
9.2.1.1US dominates the North American ATP assays market100
TABLE 33US: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)100
TABLE 34US: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)101
TABLE 35US: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)101
TABLE 36US: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)101
TABLE 37US: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)102
9.2.2CANADA102
9.2.2.1Government funding programs for life science research to drive market growth102
TABLE 38CANADA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)103
TABLE 39CANADA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)103
TABLE 40CANADA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)103
TABLE 41CANADA: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)104
TABLE 42CANADA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)104
9.3EUROPE104
FIGURE 31EUROPE: PHARMACEUTICAL R&D EXPENDITURE, 2000–2018 (USD BILLION)105
TABLE 43EUROPE: ATP ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)106
TABLE 44EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)106
TABLE 45EUROPE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)106
TABLE 46EUROPE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)107
TABLE 47EUROPE: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)107
TABLE 48EUROPE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)107
9.3.1GERMANY108
9.3.1.1Demand for ATP assays is driven by the large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers108
TABLE 49GERMANY: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)109
TABLE 50GERMANY: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)109
TABLE 51GERMANY: ATP INSTRUMENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)109
TABLE 52GERMANY: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)110
TABLE 53GERMANY: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)110
9.3.2UK110
9.3.2.1UK has the largest pharmaceutical R&D expenditure in Europe110
TABLE 54UK: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)111
TABLE 55UK: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)111
TABLE 56UK: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)112
TABLE 57UK: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)112
TABLE 58UK: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)112
9.3.3FRANCE113
9.3.3.1Strong agro-food sector and a major focus on biotechnology
R&D to drive market growth in France113
TABLE 59FRANCE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)113
TABLE 60FRANCE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)114
TABLE 61FRANCE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)114
TABLE 62FRANCE: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)114
TABLE 63FRANCE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)115
9.3.4ITALY115
9.3.4.1High cancer burden to increase the demand for ATP assays in Italy115
TABLE 64ITALY: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)116
TABLE 65ITALY: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)116
TABLE 66ITALY: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)116
TABLE 67ITALY: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)117
TABLE 68ITALY: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)117
9.3.5SPAIN117
9.3.5.1Growth in the personalized medicine sector and clinical diagnostics market to drive the ATP assays market in Spain117
TABLE 69SPAIN: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)118
TABLE 70SPAIN: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)118
TABLE 71SPAIN: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)119
TABLE 72SPAIN: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)119
TABLE 73SPAIN: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)119
9.3.6REST OF EUROPE120
TABLE 74ROE: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)120
TABLE 75ROE: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)121
TABLE 76ROE: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)121
TABLE 77ROE: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)121
TABLE 78ROE: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)122
9.4ASIA PACIFIC122
FIGURE 32ASIA PACIFIC: ATP ASSAYS MARKET SNAPSHOT123
TABLE 79ASIA PACIFIC: ATP ASSAYS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)124
TABLE 80ASIA PACIFIC: ATP ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)124
TABLE 81ASIA PACIFIC: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)124
TABLE 82ASIA PACIFIC: ATP INSTRUMENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)125
TABLE 83ASIA PACIFIC: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)125
TABLE 84ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER,
2020–2027 (USD MILLION)125
9.4.1CHINA126
9.4.1.1Increasing pharmaceutical R&D investments in the country to support market growth126
TABLE 85CHINA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)126
TABLE 86CHINA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)127
TABLE 87CHINA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)127
TABLE 88CHINA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)127
TABLE 89CHINA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)128
9.4.2JAPAN128
9.4.2.1High incidence of cancer to increase the demand for
ATP assays in Japan128
TABLE 90JAPAN: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)129
TABLE 91JAPAN: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)129
TABLE 92JAPAN: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)130
TABLE 93JAPAN: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)130
TABLE 94JAPAN: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)130
9.4.3INDIA131
9.4.3.1Growing adoption of ATP assay techniques in research and clinical applications to drive the market in India131
TABLE 95INDIA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)131
TABLE 96INDIA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)132
TABLE 97INDIA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)132
TABLE 98INDIA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)132
TABLE 99INDIA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)133
9.4.4REST OF APAC133
TABLE 100ROAPAC: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)134
TABLE 101ROAPAC: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)134
TABLE 102ROAPAC: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)134
TABLE 103ROAPAC: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)135
TABLE 104ROAPAC: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)135
9.5LATIN AMERICA135
TABLE 105LATIN AMERICA: ATP ASSAYS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)136
TABLE 106LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)136
TABLE 107LATIN AMERICA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2020–2027 (USD MILLION)137
TABLE 108LATIN AMERICA: ATP INSTRUMENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)137
TABLE 109LATIN AMERICA: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)137
TABLE 110LATIN AMERICA: ATP ASSAYS MARKET, BY END USER,
2020–2027 (USD MILLION)138
9.5.1BRAZIL138
9.5.1.1Increasing research activities & expanding pharmaceutical market in Brazil is fueling the market for ATP assays138
TABLE 111BRAZIL: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)139
TABLE 112BRAZIL: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)139
TABLE 113BRAZIL: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)139
TABLE 114BRAZIL: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)140
TABLE 115BRAZIL: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)140
9.5.2MEXICO140
9.5.2.1Increase in research centers and manufacturing to drive the demand for ATP assays in Mexico140
TABLE 116MEXICO: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)141
TABLE 117MEXICO: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)141
TABLE 118MEXICO: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)142
TABLE 119MEXICO: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)142
TABLE 120MEXICO: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)142
9.5.3REST OF LATIN AMERICA143
TABLE 121ROLATAM: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)143
TABLE 122ROLATAM: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)143
TABLE 123ROLATAM: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)144
TABLE 124ROLATAM: ATP ASSAYS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)144
TABLE 125ROLATAM: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)144
9.6MIDDLE EAST & AFRICA145
9.6.1GROWING FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IS DRIVING MARKET GROWTH IN THE MEA145
TABLE 126MEA: ATP ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)145
TABLE 127MEA: ATP CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2020–2027 (USD MILLION)146
TABLE 128MEA: ATP INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)146
TABLE 129MEA: ATP ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)146
TABLE 130MEA: ATP ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)147
10COMPETITIVE LANDSCAPE148
10.1OVERVIEW148
10.2KEY PLAYER STRATEGIES/RIGHT TO WIN148
10.2.1OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN
THE ATP ASSAYS MARKET149
10.3REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS151
FIGURE 33REVENUE ANALYSIS OF THE TOP PLAYERS IN THE ATP ASSAYS MARKET151
10.4MARKET RANKING ANALYSIS151
FIGURE 34ATP ASSAYS MARKET RANKING, BY KEY PLAYER, 2021152
10.5COMPETITIVE LEADERSHIP MAPPING153
10.5.1STARS153
10.5.2EMERGING LEADERS153
10.5.3PERVASIVE PLAYERS153
10.5.4PARTICIPANTS153
FIGURE 35ATP ASSAYS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)154
10.6COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS154
10.6.1PROGRESSIVE COMPANIES154
10.6.2DYNAMIC COMPANIES155
10.6.3STARTING BLOCKS155
10.6.4RESPONSIVE COMPANIES155
FIGURE 36ATP ASSAYS MARKET: COMPETITIVE LEADERSHIP
MAPPING FOR STARTUPS (2021)155
10.7COMPANY FOOTPRINT156
TABLE 131COMPANY FOOTPRINT: ATP ASSAYS MARKET (2021)156
10.7.1PRODUCT FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET157
TABLE 132PRODUCT FOOTPRINT: ATP ASSAYS MARKET (2021)157
10.7.2APPLICATION FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET158
TABLE 133APPLICATION FOOTPRINT: ATP ASSAYS MARKET (2021)158
10.7.3END-USER FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET159
TABLE 134END-USER FOOTPRINT: ATP ASSAYS MARKET (2021)159
10.7.4GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE ATP ASSAYS MARKET160
TABLE 135GEOGRAPHIC FOOTPRINT: ATP ASSAYS MARKET (2021)160
10.8COMPETITIVE SCENARIO161
10.8.1PRODUCT LAUNCHES161
TABLE 136PRODUCT LAUNCHES, JANUARY 2018–FEBRUARY 2022161
10.8.2DEALS162
TABLE 137DEALS, JANUARY 2018–FEBRUARY 2022162
10.8.3OTHER DEVELOPMENTS164
11COMPANY PROFILES165
11.1KEY PLAYERS165
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1THERMO FISHER SCIENTIFIC, INC.165
TABLE 139THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW165
FIGURE 37THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)166
11.1.2PROMEGA CORPORATION170
TABLE 140PROMEGA CORPORATION: BUSINESS OVERVIEW170
11.1.3MERCK KGAA173
FIGURE 38MERCK KGAA: COMPANY SNAPSHOT (2021)174
11.1.4NEOGEN CORPORATION177
TABLE 142NEOGEN CORPORATION: BUSINESS OVERVIEW177
FIGURE 39NEOGEN CORPORATION: COMPANY SNAPSHOT (2021)178
11.1.5PERKINELMER, INC.181
FIGURE 40PERKINELMER, INC.: COMPANY SNAPSHOT (2021)182
11.1.6AGILENT TECHNOLOGIES, INC.185
FIGURE 41AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2021)186
11.1.7PROMOCELL GMBH189
11.1.8DANAHER CORPORATION190
FIGURE 42DANAHER CORPORATION: COMPANY SNAPSHOT (2021)191
11.1.9LONZA GROUP193
TABLE 147LONZA GROUP: BUSINESS OVERVIEW193
FIGURE 43LONZA GROUP: COMPANY SNAPSHOT (2021)194
11.1.10ABCAM PLC196
FIGURE 44ABCAM PLC: COMPANY SNAPSHOT (2021)197
11.1.113M199
FIGURE 453M: COMPANY SNAPSHOT (2021)200
11.1.12ABNOVA CORPORATION201
FIGURE 46ABNOVA CORPORATION: COMPANY SNAPSHOT (2020)201
11.1.13GENO TECHNOLOGY, INC.203
TABLE 151GENO TECHNOLOGY, INC.: BUSINESS OVERVIEW203
11.1.14AAT BIOQUEST, INC.205
TABLE 152AAT BIOQUEST, INC.: BUSINESS OVERVIEW205
11.1.15BIOTHEMA AB207
11.1.16BIOTIUM209
11.1.17CREATIVE BIOARRAY210
11.1.18CANVAX BIOTECH S.L.211
11.1.19ELABSCIENCE BIOTECHNOLOGY INC.212
11.1.20MBL INTERNATIONAL CORPORATION213
TABLE 158MBL INTERNATIONAL CORPORATION: BUSINESS OVERVIEW213
11.2OTHER COMPANIES214
11.2.1RUHOF CORPORATION214
11.2.2CHARM SCIENCES215
11.2.3BIO SHIELD TECH, LLC216
11.2.4CAYMAN CHEMICAL217
11.2.5CELL SIGNALING TECHNOLOGY217
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12APPENDIX218
12.1INSIGHTS FROM INDUSTRY EXPERTS218
12.2DISCUSSION GUIDE219
12.3KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL223
12.4AVAILABLE CUSTOMIZATIONS225
12.5RELATED REPORTS225
12.6AUTHOR DETAILS226

Report Title: ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity

Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity

Asia Pacific Rehabilitation Equipment Market 2021-2031 by Product (Daily Living Aids, Exercise Equipment, Body Support Devices, Mobility Equipment), Application (Physiotherapy, Occupational Therapy, Others), End User (Hospitals & Clinics, Rehab Centers, Homecare Settings, Physiotherapy Centers, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Rehabilitation Equipment Market 2021-2031 by Product (Daily Living Aids, Exercise Equipment, Body Support Devices, Mobility Equipment), Application (Physiotherapy, Occupational Therapy, Others), End User (Hospitals & Clinics, Rehab Centers, Homecare Settings, Physiotherapy Centers, Others), and Country: Trend Forecast and Growth Opportunity